Neoepitopes as Difference Makers for General Cancer Vaccines?
Sign Up to like & getrecommendations! Published in 2020 at "Clinical Cancer Research"
DOI: 10.1158/1078-0432.ccr-20-2127
Abstract: The cancer mutanome has been associated with disease prognosis as well as response to interventional immunotherapy and provides a substrate for development of personalized vaccines targeting tumor neoepitopes. Recent findings suggest that neoantigen-based vaccines may… read more here.
Keywords: makers general; general cancer; cancer; neoepitopes difference ... See more keywords